Kwality Pharmaceuticals Limited (BOM:539997)
India flag India · Delayed Price · Currency is INR
3,590.75
+146.00 (4.24%)
At close: Aug 17, 2026

Kwality Pharmaceuticals Balance Sheet

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
-7.36120.222.5830.791.35
Short-Term Investments
-28.5627.3536.8642.9438.16
Cash & Short-Term Investments
35.9235.92147.5559.4473.63129.51
Cash Growth
-75.65%-75.65%148.25%-19.28%-43.14%26.40%
Accounts Receivable
-2,8011,5431,144716.94691.31
Other Receivables
-88.2127.94163.8268.9688.01
Receivables
-2,8891,6711,308785.91779.32
Inventory
-782.52834.66783.87863.15533.6
Other Current Assets
-349.6184.57275.9349.31835.76
Total Current Assets
-4,0572,8382,4272,0722,278
Property, Plant & Equipment
-1,6671,4401,3911,3481,039
Long-Term Investments
----9.327.82
Other Intangible Assets
-58.4517.07---
Long-Term Deferred Tax Assets
-25.0216.150.25--
Other Long-Term Assets
-114.52161.88124.4107.1281.08
Total Assets
-5,9224,4733,9423,5363,406

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
-1,017557.93443.17351.92345.15
Accrued Expenses
-26.2412.7326.248.485.58
Short-Term Debt
-1,011973.26785.59629.61337.23
Current Portion of Long-Term Debt
-----91.8
Current Portion of Leases
-0.06----
Current Income Taxes Payable
-81.9759.3165.2164.84410
Other Current Liabilities
-119.4691.82198.29204.6205.1
Total Current Liabilities
-2,2551,6951,5191,2591,395
Long-Term Debt
-294151.19195.6273.03202.88
Long-Term Leases
-2.4----
Pension & Post-Retirement Benefits
-11.832.522.169.037.53
Long-Term Deferred Tax Liabilities
----4.112.75
Other Long-Term Liabilities
-59.450---
Total Liabilities
-2,6231,8491,7161,5461,608

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
-103.76103.76103.76103.76103.76
Additional Paid-In Capital
-84.6884.6884.6884.68-
Retained Earnings
-3,1202,4442,0461,8091,700
Comprehensive Income & Other
-7.687.717.6388.04
Total Common Equity
3,3163,3162,6402,2422,0051,811
Minority Interest
--16.75-16.52-16.28-14.47-13.55
Shareholders' Equity
3,2993,2992,6242,2261,9911,798
Total Liabilities & Equity
-5,9224,4733,9423,5363,406

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
1,3071,3071,124981.19902.64631.92
Net Cash (Debt)
-1,271-1,271-976.9-921.75-829-502.41
Net Cash Growth
------
Net Cash Per Share
-122.51-122.51-94.15-88.83-79.89-48.42
Filing Date Shares Outstanding
10.3810.3810.3810.3810.3810.38
Total Common Shares Outstanding
10.3810.3810.3810.3810.3810.38
Working Capital
-1,8021,143908.39812.54883.33
Book Value Per Share
319.57319.57254.48216.08193.25174.58
Tangible Book Value
3,2583,2582,6232,2422,0051,811
Tangible Book Value Per Share
313.94313.94252.83216.08193.25174.58
Buildings
-578.57-519.84281.53228.11
Machinery
-1,728-1,3571,272966.75
Construction In Progress
-170.06--142.92121.49